CLINICAL_TRIALS
trial_result
· 2022-02-04
Clinical Trial Update: Circulating NEP and NEP Inhibition Study in Heart Failure With Preserved Ejection Fraction [Phase 4]
Summary
Phase 4 trial update on circulating NEP and NEP inhibition in heart failure with preserved ejection fraction (HFpEF).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Mayo Clinic | Conditions: Heart Failure With Preserved Ejection Fraction | Phase 4 | Status: COMPLETED | Results posted: 2022-02-04